A bill passed in the Senate will provide measures to speed up the development of treatments for people who desperately need them.
Drug makers could strike big with new treatments for rare diseases, according to a new report by a market research firm.
More than 400 drugs are in late-stage clinical development or awaiting Food and Drug Administration approval as treatments for rare diseases, according to a report by the drug industry lobby.
A nationwide, patient-centered health management organization, serving patients with rare, ultra-orphan disorders, is supporting the...